JAZZ

230.2602.62%
RI

Robert Iannone

Executive VP, Chief Medical Officer and Global Head of Research & Development

Dr. Robert Iannone, also known as Rob, M.D., M.S.C.E., is Independent Director of Pliant Therapeutics, Inc. since July 09, 2026. He is Scientific Advisory Board Member of Crossbow Therapeutics, Inc. Dr. Robert Iannone has been the Executive Vice President, Global Head of Research and Development at Jazz Pharmaceuticals since May 2019 and its Chief Medical Officer since September 2024. He joined Crossbow’s Scientific Advisory Board in October 2023, bringing vast expertise in preclinical and clinical drug development across therapeutic areas and phases of development. From 2001 to 2004, Dr. Iannone was an Assistant Professor of Pediatrics and from 2004 to 2012 as Adjunct Assistant Professor of Pediatrics at the University of Pennsylvania School of Medicine. During his tenure at Merck Co., Inc. (2004-2014) he took on increasingly senior management roles, culminating in his role as Executive Director and Section Head of Oncology Clinical Development. From 2014 to 2018, he served in the roles of Senior Vice President and Head of Immuno-oncology, Global Medicines Development and the Global Products Vice President at AstraZeneca plc, before joining Immunomedics, Inc., where he served as Head of Research and Development and Chief Medical Officer. Dr. Iannone has served and continues to serve on the board of several clinical-stage biotech companies, including Jounce Therapeutics, iTeos Therapeutics and Autolus Therapeutics. Dr. Iannone is Member of Scientific & Medical Advisory Board of FamiCord AG. He has also served on the Cancer Steering Committee of the Biomarkers Consortium/Foundation for the National Institutes of Health since 2011 and is currently on the Executive Committee of the Biomarkers Consortium. Dr. Iannone received a B.S. from The Catholic University of America, an M.D. from Yale University with Alpha Omega Alpha distinction and an M.S.C.E. from University of Pennsylvania. He completed his residency and chief residency in pediatrics and a fellowship in pediatric hematology-oncology at Johns Hopkins University.

Positions